Addex Therapeutics Ltd. - ADXN Net Assets per Single Share
The book value per share trend for Addex Therapeutics (ADXN) reflects current capital dynamics, where the 2.21 mark indicates the level of net assets. Growth is supported by computer modeling of allosteric modulators to automate compound screening. The strategy relies on licensing agreements and joint developments with mid-sized pharma companies, complementing the creation of safe drugs for epilepsy and Parkinson's disease.
addextherapeutics.com - analytical breakdowns and key metrics (ADXN)
- price and consensus price forecast:
- market capitalization data:
- book capitalization data:
- debt and liquidity data:
Fundamental company valuation:Addex Therapeutics, Ltd., ADXN
Addex Therapeutics' development of innovative CNS receptor modulation methods requires significant R&D capital expenditures. Analyzing the book value per share under RAS, an investor sees the remaining net assets after deducting all liabilities, allocated per single security. The stability of this metric confirms the preservation of the company's internal capital and the absence of critical write-downs, signaling the business's financial resilience.
Competitors of Addex Therapeutics (ADXN)
Biogen Corp (BIIB) - Accounting Value per Share|NBIX: Equity per Share|Net Assets per Single Share Regencell Bioscience|AXSM (axsome.com) - Equity per Share|Net Assets per Single Share ACADIA Pharmaceuticals Inc. (ACAD)|Equity per Share Xenon Pharmaceuticals Inc.|Viking Pharma - Book Value per Share|Net Asset Value per Share Supernus Corp SUPN|Accounting Value per Share CPRX (Catalyst Pharmaceuticals)|denalitherapeutics.com - Book Value per Share|Net Assets per Single Share Harmony Biosciences Holdings, Inc. (HRMY)|BHVN: Accounting Value of a Share|Net Assets per Single Share AMLX|Trevi Corp (TRVI) - Net Asset Value per Share|PRAX (Praxis Precision Medicines) - Book Value per Share|Book Value per Share anavex.com|Book Value per Share CeriBell CBLL|Equity per Share Prothena Corporation (PRTA)|ALEC - Book Value per Share|Equity per Share Annexon Biosciences Inc. ANNX|OMER (Omeros Corp.) - Book Value per Share|neurogene.com (NGNE) - Net Asset Value per Share|Accounting Value per Share AC Immune SA|Equity per Share Voyager Therapeutics Inc|NMRA - Accounting Value per Share|Accounting Value of a Share Scilex Holding Company, Inc. (SCLX)|Accounting Value per Share Tevogen Bio Holdings|Book Price of a Share alphacognition.com (ACOG)|Book Value per Share Cognition Therapeutics|Accounting Value of a Share Inhibikase Therapeutics Inc IKT|SAVA (Cassava) - Book Value per Share|ASRT: Net Asset Value per Share|Net Assets per Single Share coyatherapeutics.com COYA|Vistagen (VTGN) - Accounting Value of a Share|OVID (Ovid Therapeutics Inc) - Book Value per Share|Book Value per Share ABOS|CRVO - Net Assets per Single Share|Share Book Value alteritytherapeutics.com (ATHE)|CLNN: Book Value per Share|PEPG - Net Asset Value per Share|Jupiter Neurosciences Inc - Accounting Value per Share|Relmada Therapeutics Inc (RLMD) - Book Value per Share|ANVS - Accounting Value per Share|Grace Therapeutics (GRCE) - Book Price of a Share|AIFF: Book Value per Share|Net Assets per Share ANEW Medical, Inc.|Book Value per Share NRSN (NeuroSense Therapeutics)|Accounting Value per Share RVPH (Reviva Pharmaceuticals Holdings Inc.)|Net Assets per Single Share MTVA|Net Assets per Share NeurAxis Inc NRXS|Helius Medical Technologies Inc. - Book Value per Share|PASG - Book Value per Share|Book Value per Share bionomics.com.au|Equity per Share Minerva Neurosciences Inc|Accounting Value per Share Athira (ATHA)|Equity per Share ALZN|Net Assets per Single Share Cyclerion Therapeutics CYCN|Equity per Share PTIX (protagenic.com)|KTTA - Net Assets per Single Share|Equity per Share Cortigent Inc CRGT|ATXI (Avenue Therapeutics, Inc) - Book Value per Share|BrainStorm Cell Therapeutics Inc. (BCLI) - Net Asset Value per Share|CARA: Accounting Value per Share|CHRO (chromocell.com) - Book Value per Share|ELYM - Net Assets per Single Share|Accounting Value of a Share ITCI|Longboard Pharma - Net Assets per Single Share|Net Asset Value per Share Marinus Pharma (MRNS)|Book Value per Share NKGN (NKGen Biotech, Inc.)|Book Value per Share neurobopharma.com NRBO|Sage Therapeutics (SAGE) - Book Value per Share|SNPX - Equity per Share|Book Value per Share Trevena, Inc|Vigil Neuroscience, Inc. (VIGL) - Equity per Share|Book Value per Share WENA (Anew Medical)|Net Asset Value per Share cerevel.com (CERE)